3'-(4-morpholinyl)-3'-deaminodaunorubicin has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acton, EM; Fujiwara, AN; Mosher, CW; Wu, HY | 1 |
| Groth, G; Marquardt, H; Steinheider, G; Westendorf, J | 1 |
2 other study(ies) available for 3'-(4-morpholinyl)-3'-deaminodaunorubicin and Leukemia L 1210
| Article | Year |
|---|---|
Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; DNA, Neoplasm; Leukemia L1210; Leukemia P388; Mice; Structure-Activity Relationship | 1982 |
Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinodaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin.
Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chemical Phenomena; Chemistry; Chromosome Aberrations; Daunorubicin; DNA; DNA Repair; Doxorubicin; Leukemia L1210; Liver; Rats | 1985 |